Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries-Reference-Cited by-同舟云学术

Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries

Published:2021-12-31 Issue:3 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Mailankody Sharada¹²^ORCID,Kumar Venkatesan Sampath³,Khan Shah Alam³,Banavali Shripad D.⁴,Bajpai Jyoti⁴^ORCID

Affiliation:

1. Department of Medical Oncology, Manipal Comprehensive Cancer Care Centre Kasturba Medical College Manipal Karnataka India

2. Manipal Academy of Higher Education Manipal Karnataka India

3. Department of Orthopedics All India Institute of Medical Sciences New Delhi India

4. Department of Medical Oncology, Tata Memorial Center Homi Bhabha National Institute (HBNI), Mumbai, Maharasthra, India

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29540

Reference116 articles.

1. Cancer facts and figures.American Cancer Society;2020. Accessed May 5 2020.https://www.cancer.org/content/dam/cancer‐org/research/cancer‐facts‐and‐statistics/annual‐cancer‐facts‐and‐figures/2020/cancer‐facts‐and‐figures‐2020.pdf

2. The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

3. Current questions in bone sarcomas

4. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncofertility and Pregnancy in Adolescent and Young Adult Cancers: Physicians' Knowledge and Preferences in India;JCO Global Oncology;2024-01

2. Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review;Cancer Medicine;2023-08

3. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand;Cancers;2023-03-26

4. The bioinformatic approach identifies PARM1 as a new potential prognostic factor in osteosarcoma;Frontiers in Oncology;2023-03-06

5. Methotrexate Induces an Antioxidant Hormetic Response in Primary Rat Astrocytes;Dose-Response;2022-07